Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cells

29 May 2018

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autophagy in Disease and Therapy
Share to Epigenetics and DNA Methylation
Share to Histone Deacetylase Inhibitors Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 29845424
DOI: 10.1007/s00204-018-2229-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cellsPMID 29845424Read ↗

Comprehensive analysis of a new prognosis signature based on histone deacetylases in clear cell renal cell carcinoma.Semantic proximity Read ↗

Identification of HDAC10 as a candidate oncogene in clear cell renal carcinoma that facilitates tumor proliferation and metastasis.Semantic proximity Read ↗

Clinical significance of histone deacetylases 1, 2, 3, and 7: HDAC2 is an independent predictor of survival in HCCSemantic proximity Read ↗

Histone deacetylases and their inhibitors in kidney diseasesSemantic proximity Read ↗

Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancerSemantic proximity Read ↗

Targeting histone deacetylases for the treatment of cancer and inflammatory diseasesSemantic proximity Read ↗

Histone Deacetylase Inhibitors in the Treatment of Hematological Malignancies and Solid TumorsSemantic proximity Read ↗

Histone-Deacetylase Inhibitors for the Treatment of CancerSemantic proximity Read ↗

Role of histone deacetylase inhibitors in non-neoplastic diseasesSemantic proximity Read ↗

Role of HDACs in normal and malignant hematopoiesisSemantic proximity Read ↗

HDAC11: A novel target for improved cancer therapySemantic proximity Read ↗

HDAC and HDAC Inhibitor: From Cancer to Cardiovascular DiseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.